Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?—Current Status

Ischemic stroke is one of the leading causes of death worldwide. Clinical manifestations of stroke are long-lasting and causing economic burden on the patients and society. Current therapeutic modalities to treat ischemic stroke (IS) are unsatisfactory due to the intricate pathophysiology and poor f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Mol Sci
Päätekijät: Bulygin, Kirill V., Beeraka, Narasimha M., Saitgareeva, Aigul R., Nikolenko, Vladimir N., Gareev, Ilgiz, Beylerli, Ozal, Akhmadeeva, Leila R., Mikhaleva, Liudmila M., Torres Solis, Luis Fernando, Solís Herrera, Arturo, Avila-Rodriguez, Marco F., Somasundaram, Siva G., Kirkland, Cecil E., Aliev, Gjumrakch
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2020
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7555634/
https://ncbi.nlm.nih.gov/pubmed/32937836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21186728
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia